MetLife, Inc. is rated a buy due to its solid value, above-market dividend yield, and favorable technical chart despite ...

Welcome to the MetLife Fourth ... company's effective tax rate on adjusted earnings in the quarter was 23.5%, modestly below our 2024 guidance range of 24% to 26%. On Page 5, this chart reflects ...

The insurance industry is anticipated to have gained on rate hikes, strong retention rates, new business growth, an active ...

We recently published a list of 12 Best Health Insurance Stocks to Buy in 2025. In this article, we are going to take a look at where MetLife ... annual growth rate (CAGR) of 3.7% during 2025-2033 ...

In a report released today, Bob Huang from Morgan Stanley maintained a Buy rating on Metlife (MET – Research Report), with a price target of ...

We recently published a list of 12 Best Health Insurance Stocks to Buy in 2025. In this article, we are going to take a look at where MetLife ... Lower interest rates are expected to have ...

The iconic Manhattan office tower is slated for a $1.5 billion 10-year refinance, scheduled to price at a 6.25 percent ...

Looking at stellar Q4 results, strong US commercial growth, and increasing AI adoption, here’s what we think of Palantir stock. We sell different types of products and services to both ...

MetLife, Inc. (NYSE: MET) today announced its full year and fourth quarter 2024 results. Full Year Results Summary Net income of $4.2 billion, compared to net income ...